Focus on Patients
-
Addressing Underrepresentation In Cancer Trials: A Q&A With Stand Up To Cancer & Triage Cancer
2/13/2024
Clinical Leader heard from both sides of the collaboration — SU2C researcher Dr. Chanita Hughes-Halbert, Ph.D., and grant recipient Triage Cancer co-founder and COO Monica Fawzy Bryant, Esq. — to explore each’s efforts to together bring health equity to those diagnosed with cancer.
-
FDA Guidance On Standardizing Diversity And Inclusion Terminology And Collection
2/9/2024
Last week, the FDA issued a new draft guidance titled Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products.
-
Incorporating SOGI Data In Clinical Research And Impacts On Enhancing Cancer Treatment Outcomes
2/2/2024
Collecting and measuring SOGI information in cancer care and clinical trials is critical to ensuring equitable and effective care for all individuals.
-
4 Things I'm Looking Forward To At SCOPE 2024
2/1/2024
The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.
-
Ensuring Diversity And Accessibility In Neurological Research
1/26/2024
The landscape of neurological and rare disorders is as diverse as the human population it affects. Yet, clinical trials for these conditions have not always mirrored this diversity.
-
Understanding Precision Neuroscience As Treatment For Rare Autoantibody Disease
1/19/2024
J&J Innovative Medicine develops precision therapeutics in neuroscience, reducing the trial participation and treatment burdens on people living with generalized myasthenia gravis.
-
Patient Engagement Needs More Benefit Analysis, Fewer Theoretical Conversations
1/12/2024
Are companies just tagging on to the status quo of being “patient-centric” without fully analyzing the return on investment for their company? Consultant and patient advocate Ella Balasa discusses.
-
Why We Need More Women In Clinical Research — Now
1/10/2024
Society’s tendency to view the male body as “default” has had relatively benign, if not uncomfortable, effects. But, gender bias can have serious consequences, including in clinical research.
-
What Rare Disease Patients Want Sponsors To Know
1/9/2024
A rare disease caregiver and patient, Sabina Kineen hopes to shine a light on the importance of clinical trial education for patients and caregivers and how sponsors can support them.
-
What Experts Think Will Happen With Patient Centricity In 2024
12/27/2023
In part two, experts discuss patient centricity themes, including diversity, equity, and inclusion (DEI) and precision medicine, in the clinical trials industry as we move into 2024.